Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2024-09-17 00:00:00 ET · period of report 2024-09-14 · accession 0001415889-24-023549 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-17 | 2024-09-16 | ANAB | MULROY DENNIS | CFO | S - Sale+OE | $39.91 | -12.2K | 4,744 | -72% | -$487.7K |
| DM | 2024-09-17 | 2024-09-14+ | ANAB | MULROY DENNIS | CFO | M - OptEx | $20.16 | +16.0K | 6,964 | New | +$322.6K |
| DM | 2024-09-17 | 2024-09-14+ | ANAB | MULROY DENNIS | CFO | M - OptEx | $0.00 | -16.0K | 80.6K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-16 | S | D | 10,000 | $40.13 | 4,744 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-16 | M | A | 10,000 | $20.16 | 14,744 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-16 | S | D | 2,220 | $38.93 | 4,744 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-14 | M | A | 6,000 | — | 6,964 | D | — | — | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| 5 | Derivative | Restricted Stock Unit | 2024-09-14 | M | D | 6,000 | $0.00 | 0 | D | — · — to — | 6,000 Common Stock | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F4) 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2024-09-16 | M | D | 10,000 | $0.00 | 80,600 | D | $20.16 · — to 2030-07-12 | 10,000 Common Stock | (F6) In addition to the remaining options to purchase 80,600 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 263,040 shares of common stock, which options vest according to their terms. (F5) The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 15, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |